Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hepatitis C virus genotype 3 and the risk of severe liver disease in a large population of drug users in France.

Journal of medical virology - 1 Oct 2010

Larsen Christine, Bousquet Vanina, Delarocque-Astagneau Elisabeth, Pioche Corinne, Roudot-Thoraval Françoise, Desenclos Jean-Claude

Abstract excerpt

Although risk factors for cirrhosis in chronic hepatitis C virus (HCV) infection have been identified, the role of HCV-genotype 3 remains controversial, and limited data are available in drug users. The aim of the study was to assess risk factors for severe liver disease (cirrhosis/hepatocellular carcinoma) in HCV-infected drug users between 2001 and 2007 in France. Patients who reported drug use and who had been...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Hepatocellular
Share to Drug Users

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to France

Share to Hepacivirus

Share to Hepatitis C, Chronic

Share to Liver Cirrhosis

Share to Liver Neoplasms

Share to Severity of Illness Index

Source

Identifiers

PMID: 20827760
DOI: 10.1002/jmv.21850

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hepatitis C virus genotype 3 and the risk of severe liver disease in a large population of drug users in France.PMID 20827760Read ↗

HCV genotype 3 is associated with an increased risk of cirrhosis and hepatocellular cancer in a national sample of U.S. Veterans with HCV.Semantic proximity Read ↗

Hepatitis C virus infection: Are there still specific problems with genotype 3?Semantic proximity Read ↗

Hepatitis C virus genotype 3 predominates in North and Central India and is associated with significant histopathologic liver disease.Semantic proximity Read ↗

Hepatitis C Virus: Current and Evolving Treatments for Genotypes 2 and 3.Semantic proximity Read ↗

Exploring differences in response to treatment with peginterferon alpha 2a (40kD) and ribavirin in chronic hepatitis C between genotypes 2 and 3.Semantic proximity Read ↗

Incidence and predictors of severe liver fibrosis in HIV-infected patients with chronic hepatitis C in Brazil.Semantic proximity Read ↗

Review article: HCV genotype 3 – the new treatment challenge.Semantic proximity Read ↗

Infection With Hepatitis C Virus Genotype 3 Is an Independent Risk Factor for End-Stage Liver Disease, Hepatocellular Carcinoma, and Liver-Related Death.Semantic proximity Read ↗

Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C.Semantic proximity Read ↗

Impact of hepatitis C virus genotype 3 on liver disease progression in a Chinese national cohort.Semantic proximity Read ↗

Predictive factors for sustained virological response after treatment with pegylated interferon α-2a and ribavirin in patients infected with HCV genotypes 2 and 3.Semantic proximity Read ↗

Is genotype 3 of the hepatitis C virus the new villain?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.